Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | YMAB Y-mAbs Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 105,300 | 0.00 | 141,000 |
17 Jan 25 | YMAB Y-mAbs Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 6.16 | 210,700 | 1.30 mm | 210,700 |
12 Feb 24 | YMAB Y-mAbs Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 35,700 | 0.00 | 35,700 |
12 Feb 24 | YMAB Y-mAbs Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 54,000 | 0.00 | 54,000 |
12 Feb 24 | YMAB Y-mAbs Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 14.36 | 214,200 | 3.08 mm | 214,200 |
6 Nov 23 | YMAB Y-mAbs Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 5.75 | 615,240 | 3.54 mm | 615,240 |
1 Nov 23 | MIR Mirion | Class A Common Stock | Payment of exercise | Dispose F | No | No | 6.93 | 5,514 | 38.21 k | 116,173 |